Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SendGrid is a cloud-based customer communication platform that provides a scalable and reliable infrastructure for transactional and marketing email delivery. While primarily a technology company, SendGrid is significant in the healthcare and life sciences sectors for its HIPAA-compliant email solutions, which allow providers and pharmaceutical companies to securely communicate with patients. The platform offers advanced deliverability features, APIs, and analytics to ensure that critical health notifications and marketing messages reach their intended recipients. Following its acquisition by Twilio in 2019 for approximately $3 billion, SendGrid has been integrated into the Twilio communications suite as Twilio SendGrid.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SendGrid.